Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1989-04-12
1991-01-29
Bond, Robert T.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514212, 514422, 514426, 540480, 546208, 546207, 546277, 546143, 546144, 546159, 546167, 548518, 548517, 548557, 548162, 548212, 548233, 548245, 548167, 548471, 548453, 548217, 548305, 544333, 544336, 544238, 544237, 544284, 544353, 544235, A61K 31445, C07D40104
Patent
active
049887114
ABSTRACT:
Inhibiting HMG-CoA reductase, as in treating hyperlipopproteinaemia, lipoproteinaemia and arteriosclerosis, with the new N-substituted N-amino-pyrroles of the formula ##STR1## in which R.sup.1 is an organic radical,
Angerbauer Rolf
Bischoff Hilmar
Fey Peter
Hubsch Walter
Petzinna Dieter
Bayer Aktiengesellschaft
Bond Robert T.
LandOfFree
HMG-CoA reductare-inhibiting N-substituted N-amino-pyrroles does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with HMG-CoA reductare-inhibiting N-substituted N-amino-pyrroles, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and HMG-CoA reductare-inhibiting N-substituted N-amino-pyrroles will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-814112